Analysts Split On How To Read Intercept Switching Clinical Trial Endpoints

By: via Benzinga
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) hosted a call on Friday to divulge information about changes it made to a late-stage ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.